Quick Answer
Apyx Medical Corp reported Stockholders Equity of $14.54 million for the year ending 2025.
- Apyx Medical Corp showed an increase of +2.3% in Stockholders Equity from 2024 to 2025.
- This data is from Apyx Medical Corp's annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2008 to 2025 (20 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $22.58 million | Q3 2011: $22.68 million | Q1 2012: $22.34 million | Q2 2012: $22.52 million | Q3 2012: $22.56 million | Q1 2013: $22.55 million | Q2 2013: $21.68 million | Q3 2013: $21.42 million | Q1 2014: $9.34 million | Q2 2014: $9.61 million | Q3 2014: $6.84 million | Q1 2015: $26.19 million | Q2 2015: $26.11 million | Q3 2015: $24.62 million | Q1 2016: $21.64 million | Q2 2016: $21.30 million | Q3 2016: $20.63 million | Q1 2017: $24.70 million | Q2 2017: $23.57 million | Q3 2017: $22.52 million | Q1 2018: $21.47 million | Q2 2018: $21.57 million | Q4 2018: $87.18 million | Q1 2019: $82.83 million | Q2 2019: $79.44 million | Q3 2019: $76.73 million | Q1 2020: $70.43 million | Q2 2020: $66.84 million | Q3 2020: $64.20 million | Q1 2021: $60.04 million | Q2 2021: $57.36 million | Q3 2021: $54.35 million | Q1 2022: $49.56 million | Q2 2022: $45.91 million | Q3 2022: $41.99 million | Q1 2023: $36.05 million | Q2 2023: $36.60 million | Q3 2023: $33.35 million | Q1 2024: $20.25 million | Q2 2024: $14.75 million | Q3 2024: $11.04 million | Q1 2025: $10.51 million | Q2 2025: $7.25 million | Q3 2025: $5.85 million.
- Over the full 20 years of available data (2008 to 2025), Apyx Medical Corp's Stockholders Equity has declined by 28.1%.
- Historical annual values: Fiscal year 2025: $14.54 million | Fiscal year 2024: $14.21 million | Fiscal year 2023: $26.70 million | Fiscal year 2022: $37.58 million | Fiscal year 2021: $53.70 million | Fiscal year 2020: $63.72 million | Fiscal year 2019: $71.26 million | Fiscal year 2019: $82.83 million | Fiscal year 2018: $87.18 million | Fiscal year 2018: $90.60 million | Fiscal year 2017: $22.03 million | Fiscal year 2016: $26.22 million | Fiscal year 2015: $23.40 million | Fiscal year 2014: $1.50 million | Fiscal year 2013: $19.07 million | Fiscal year 2012: $22.90 million | Fiscal year 2011: $22.12 million | Fiscal year 2010: $21.77 million | Fiscal year 2009: $21.03 million | Fiscal year 2008: $20.22 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: